NCT05779891

Brief Summary

The goal of this clinical trial is to examine the effect of mulligan straight leg raise versus slump stretching on pain, disability and hip range of motion in patient with low back pain. . Convenient sampling technique will be used to enroll the patients. Patients will be inquire into basis of pre formulated eligibility criteria. Written Consent will be taken from each patient before starting interventional sessions. Sample size of this study will consist on the participants who will qualify for both inclusion an exclusion criteria. Both groups will receive ultrasonic therapy and hot pack therapy as baseline treatment. Group A will receive mulligan straight leg raise and group B will receive slump stretching. The assessment of patients will be done at baseline, 4th and 8th week. The outcomes from patients will be calculated by using Visual Analogue Scale (VAS), Goniometer and ODI. The comparison between pre-treatment and post-treatment data will be done after 8th week. Data will be analyzed through SPSS 25.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
48

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 7, 2023

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

March 10, 2023

Completed
12 days until next milestone

First Posted

Study publicly available on registry

March 22, 2023

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 7, 2023

Completed
23 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2023

Completed
Last Updated

March 22, 2023

Status Verified

March 1, 2023

Enrollment Period

3 months

First QC Date

March 10, 2023

Last Update Submit

March 10, 2023

Conditions

Outcome Measures

Primary Outcomes (3)

  • Low Back Pain

    Pain will be assessed by using Numerical Pain Rating Scale

    8 weeks

  • Range of motion at hip joint

    Range of motion will be assessed by using Goniometer

    8 weeks

  • Disability related to back pain

    Disability will be assessed by using Owestry Disability Index

    8 weeks

Study Arms (2)

Interventional Group A

EXPERIMENTAL
Other: Mulligan Traction Straight Leg Raise Technique

Interventional Group B

ACTIVE COMPARATOR
Other: Slump Stretching

Interventions

The individuals in the Group A will be receive hot pack at lower back for 10 minutes followed by ultrasound at 1.5w/cm2 for 10 minutes. The treatment will be preceded by Mulligan straight leg raise technique . Three repetitions of Mulligan's Traction Straight Leg Raise will be done with 7 seconds hold and 5 seconds relax time. The total treatment protocol will be 30 minutes.

Interventional Group A

The individuals in the Group B will be receive hot pack at lower back for 10 minutes followed by ultrasound at 1.5w/cm2 for 10 minutes. The treatment will be preceded by Slump Stretching technique. Five repetitions of Slump stretching technique will be done with 30 seconds hold and 5 seconds relax time. The total treatment protocol will be 30 minutes

Interventional Group B

Eligibility Criteria

Age18 Years - 25 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Patients who have active positive knee extension test(APKET).
  • Patient having low back pain for more than 3 months.
  • Patients who have been sitting for three hours.

You may not qualify if:

  • Any active infection, tumor, tuberculosis.
  • History of trauma.
  • Subject with intervertebral disc prolapse.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

District Headquarters Hospital

Faisalābad, Punjab Province, 38000, Pakistan

RECRUITING

Central Study Contacts

Sahreen Anwar, Ph.D

CONTACT

Muhammad Talha Hassan Javed, Masters

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Dr

Study Record Dates

First Submitted

March 10, 2023

First Posted

March 22, 2023

Study Start

March 7, 2023

Primary Completion

June 7, 2023

Study Completion

June 30, 2023

Last Updated

March 22, 2023

Record last verified: 2023-03

Data Sharing

IPD Sharing
Will not share

Locations